.png "Zydus Secures USFDA Nod for Leuprolide Acetate Injection")
Zydus Lifesciences receives final USFDA approval for its Leuprolide Acetate injection, the generic version of Lupron, used in the palliative treatment of advanced prostate cancer. The approval strengthens Zydus’s oncology portfolio in the US market.
.png "Alembic Pharmaceuticals Secures USFDA Nod for Diltiazem Tablets")
Alembic Pharmaceuticals today received its final USFDA clearance of its ANDA of Diltiazem Hydrochloride Tablets 30mg, 60mg, 90mg, and 120mg. This is a strategic victory that strengthens the position of the U.S. generics market of Alembic...
.png "Pfizer Completes Metsera Deal to Expand Obesity Drug Pipeline")
Pfizer acquisition news took center stage today as the company confirmed it has closed its purchase of Metsera, a clinical-stage biotech pushing new treatments for obesity and cardiometabolic disease. The move marks a major step for Pfizer as it...
Zydus Lifesciences has secured final approval from the United States Food and Drug Administration (USFDA) for its Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial, the generic equivalent of Lupron Injection (1 mg/0.2 mL)
Merck is reportedly nearing an agreement to acquire Cidara Therapeutics, in a deal that would value the biotechnology firm above its current $3.3 billion market capitalization
Sun Pharmaceutical Industries Limited (Sun Pharma), India’s leading pharmaceutical company by revenue and prescriptions, has rolled out the #SeeBeyondSugar campaign — a national initiative aimed at boosting awareness and education around diabetic
.png "Abbott Unveils New Ensure Diabetes Care Formula in India")
Abbott has introduced an improved brand of its India Diabetes Care form of the brand, Sure, focusing on science-based nutrition to individuals with diabetes. Today, the launch was announced, and is based on the results of more than 30 years of...
Indian pharma major Lupin announced today the U.S. launch of Risperidone extended-release injectable suspension in 25 mg, 37.5 mg and 50 mg single-dose vials, marking a significant strategic move in the long-acting injectable (LAI) market...
Novartis announced positive Phase III results on its innovative malaria drug GanLum. This research, referred to as KALUMA, demonstrated that GanLum achieved its primary objective and was as effective, at least, as existing standard therapies...
CN Tech Engineers (CN Water), a major Indian provider of high-purity water solutions for pharmaceutical and industrial use, has entered into a strategic alliance with Taiwan Pure Water Technology Co., Ltd. (Taipure), a leader in ultrapure water (UPW)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")